Vaccinare
Riflessioni sulle coperture vaccinali a 5-6 anni in Italia per il vaccino anti-morbillo, anni 2013-2014
Reflections on measles vaccination coverage among children aged 5-6 years old Italy 2013-2014
Luciano Pinto1, Rocco Russo2
1Società Italiana di Pediatria Preventiva e Sociale
2UO Materno Infantile, ASL Benevento
Novembre 2016 - pagg. 585 -590
Abstract
In Italy, measles vaccine became commercially available in 1976 and the Ministry of
Health has been recommending its administration since 1979. The last significant
measles epidemic in Italy occurred in the region around Naples, Campania, in 2002
when approximately 41,000 cases were reported: 95% of the reported cases were
children under 15 years old, 600 of them had to be hospitalized and among them
16 cases of encephalitis and 4 deaths were reported. Italy, as well as all the other European
countries that are member of the World Health Organisation, had committed
to eliminate endemic transmission of measles and rubella by 2015; however, even if
the incidence of these diseases had decreased, the goal has not been achieved yet.
On the 27th January 2016, for the first time the Ministry of Health published the data
regarding the coverage for the second dose of the MMR vaccine given at 5-6 years
of age for the years 2013 (cohort 2006) and 2014 (cohort 2007). The mean
measles vaccination coverage was much lower than 90% (84%) in 2013 and further
reduced in 2014 (82.72%), recording peaks of significantly lower percentages in
some southern regions. It is therefore evident that this low coverage level results in a
substantial number of children susceptible to infection and thus leads to a higher risk
of new epidemics. It is therefore necessary to take effective and rapid measures to
overcome the widespread mistrust of vaccines, in particular of the measles vaccine,
and to reverse the above-mentioned negative trend of the vaccines coverage.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Ministero della Salute. Morbillo-parotite-rosolia
(MPR), trend in diminuzione della copertura
vaccinale. 27 gennaio 2016. http://
www.salute.gov.it/portale/news/p3_2_1_1_1.j
sp?lingua=italiano&menu=notizie&p=dalministero&
id=2420.
2. Ministero della Salute. Piano nazionale per
l’eliminazione del morbillo e della rosolia congenita
2010-2015. http://www.salute.gov.it/
imgs/C_17_pubblicazioni_1519_allegato.pdf
3. Sorveglianza Integrata del Morbillo e della
Rosolia - ISS-CNESPS, Reparto Epidemiologia
delle Malattie Infettive. https://www.iss.it/site/
rmi/morbillo/.
4. Ministero della Salute. Coperture vaccinali
(%), calcolate sui riepiloghi inviati dalle Regioni
e PP.AA. Anno 2014: 1a dose entro 24 mesi
(coorte 2012) aggiornamento 25/01/2016.
http://www.salute.gov.it/imgs/C_17_tavole_
20_allegati_iitemAllegati_16_fileAllegati_it
emFile_0_file.pdf.
5. Pinto L, Di Mauro G, Bona G. Un evento
previsto: il calo delle coperture vaccinali in Italia
nel 2014. Epicentro, 22 ottobre 2015. http:
//www.epicentro.iss.it/temi/vaccinazioni/pdf
/CVanalisiSipps2015.pdf.
6. Edmunds WJ, van de Heijden OG, Eerola
M, Gay NJ. Modelling rubella in Europe. Epidemiol
Infect 2000;125(3):617-34.
7. Conferenza Stato-Regioni. Accordo tra il Ministro
della Salute, le Regioni e le Province Autonome
sul documento recante: Piano nazionale
per l’eliminazione del morbillo e della rosolia
congenita, 13 novembre 2003. http://
www.ministerosalute.it/imgs/C_17_pubblicazioni_
730_allegato.pdf.
8. Ciofi Degli Atti ML, Salmaso S, Vellucci L.
New measles epidemic in southern Italy: 1217 cases reported to sentinel surveillance, January-
May 2003. Euro Surveill 2003;7(27):
pii=2253. http://www.eurosurveillance.org/
ViewArticle.aspx?ArticleId=2253.
9. Ministero della Salute: Italia. Decreto 7 aprile
1999. Nuovo calendario delle vaccinazioni
obbligatorie e raccomandate per l’età evolutiva.
Gazzetta Ufficiale n. 87 del 15 aprile 1999.
10. Filia A, Brenna A, Panà A, Cavallaro GM,
Massari M, Ciofi degli Atti ML. Health burden
and economic impact of measles-related hospitalizations
in Italy in 2002-2003. BMC Public
Health 2007;7:169.
11. Spier RE. Perception of risk of vaccine adverse
events: a historical perspective. Vaccine
2001;20(Suppl 1):S78- 84.
12. Tickner S, Leman PJ, Woodcock A. Factors
underlying suboptimal childhood immunisation.
Vaccine 2006;24:7030-6.
13. Salmaso S. Editoriale. Torniamo a parlare
di vaccinazioni. Medico e Bambino 2015;34
(5):279-80.
14. ECDC Meeting Report. Individual decision-
making and childhood vaccination.
Stockholm, Sweden: 24 May 2013. http://
ecdc.europa.eu/en/publications/Publications/
vaccination-individual-decision-makingand-
childhood-vaccination.pdf.
15. MacDonald NE; SAGE Working Group on
Vaccine Hesitancy. Vaccine hesitancy: Definition,
scope and determinants. Vaccine 2015;
33:4161-4.
16. Kennedy A, Lavail K, Nowak G, Basket M,
Landry S. Confidence about vaccines in the
United States: understanding parents’ perceptions.
Health Aff (Millwood) 2011;30(6):1151-9.
17. Chen RT. Vaccine risks: real, perceived
and unknown. Vaccine 1999;17:S41-S46.
18. Poland GA, Jacobson RM. Understanding
those who do not understand: a brief review
of the anti-vaccine movement. Vaccine 2001;
19:2440-5.
19. WHO. Immunization, Vaccines and Biologicals.
The immunological basis for immunization
series - Module 7: Measles - Update 2009.
http://apps.who.int/iris/bitstream/10665/
44038/1/9789241597555_eng.pdf.
20. Filia A, Bella A, Rota MC, et al. Analysis of
national measles surveillance data in Italy
from October 2010 to December 2011 and
priorities for reaching the 2015 measles elimination
goal. Euro Surveill 2013;18(20):pii
=20480. Available online: http://www.eurosurveillance.
org/ViewArticle.aspx?ArticleId=
20480.
21. European Centre for Disease Prevention
and Control. Measles and rubella monitoring,
January 2016 – Reporting on January 2015-
December 2015 surveillance data and epidemic
intelligence data until 31 January 2016.
Stockholm: ECDC, 2016.
22. Filia A, Del Manso M, Rota MC, et al. Morbillo
& Rosolia News, Marzo 2016. http://
www.epicentro.iss.it/problemi/morbillo/bollettino/
RM_News_2016_25.pdf.
23. Butler R, MacDonald NE; SAGE Working
Group on Vaccine Hesitancy. Diagnosing the
determinants of vaccine hesitancy in specific
subgroups: The Guide to Tailoring Immunization
Programmes (TIP). Vaccine 2015;33:
4176-9.
24. WHO. Report of the SAGE Working Group
on Vaccine Hesitancy. http://www.who.int/
immunization/sage/meetings/2014/october/
SAGE_working_group_revised_report
_vaccine_hesitancy.pdf?ua=1vi.
25. AIFA. Cresce a livello globale l’opposizione
ai vaccini: l’OMS analizza il fenomeno ed
esplora le strategie per affrontarlo. 31 agosto
2015.
26. Dubé E, Gagnon D, Nickels E, Jeram S,
Schuster M. Mapping vaccine hesitancy-country-
specific characteristics of a global phenomenon.
Vaccine 2014;32:6649-54.
27. Commissione Vaccini della SIAIP, Gruppo
di Lavoro Vaccini e Vaccinazioni della SIPPS.
Dobbiamo cambiare per mantenere elevate le
coperture vaccinali in Italia! - RIAP 2015;19(3):
26-34. http://www.riaponline.it/wp-content/
uploads/2015/09/ RivRiap3_15. pdf.
28. European Centre for Disease Prevention
and Control. Vaccine hesitancy among healthcare
workers and their patients in Europe - A
qualitative study. Stockholm: ECDC, 2015.
29. Odone A, Fara GM, Giammaco G, Blangiardi
F, Signorelli C. The future of immunization
policies in Italy and in the European
Union: The Declaration of Erice. Hum Vaccin
Immunother 2015;11(5):1268-71.
30. Leask J, Kinnersley P, Jackson C, Cheater
F, Bedford H, Rowles G. Communicating with
parents about vaccination: a framework for
health professionals. BMC Pediatr 2012;12:
154.
31. Piccirilli G, Lazzarotto T, Chiereghin A,
Serra L, Gabrielli L, Lanari M. Spotlight on
measles in Italy: why outbreaks of a vaccinepreventable
infection continue in the 21st century.
Expert Rev Anti Infect Ther 2015;13(3):
355-62.
32. Nowak GJ, Gellin BG, MacDonald NE, Butler
R; SAGE Working Grou p on Vaccine Hesitancy.
Addressing vaccine hesitancy: The potential
value of commercial and social marketing
principles and practices. Vaccine 2015;33:
4204-11.
33. Wheeler M, Buttenheim AM. Parental vaccine
concerns, information source, and choice
of alternative immunization schedules. Hum
Vaccin Immunother 2013;9(8):1782-9.
34. Salmon DA, Haber M, Gangarosa EJ, Phillips
L, Smith NJ, Chen RT. Health consequences
of religious and philosophical exemptions
from immunization laws: individual and societal
risk of measles. JAMA 1999;282:47-53.
35. Feikin DR, Lezotte DC, Hamman RF, Salmon
DA, Chen RT, Hoffman RE. Individual
and community risks of measles and pertussis
associated with personal exemptions to immunization.
JAMA 2000;284:3145-50.
36. Omer SB, Enger KS, Moulton LH, et al.
Geographic clustering of nonmedical exemptions
to school immunization requirements
and associations with geographic clustering
of pertussis. Am J Epidemiol 2008;168:1389-
96.
37. Bätzing-Feigenbaum J, Pruckner U, Beyer
A, et al. Spotlight on measles 2010: Preliminary
report of an ongoing measles outbreak in
a subpopulation with low vaccination coverage
in Berlin, Germany, January-March 2010. Euro
Surveill 2010;15:pii=19527. Available online:
http://www.eurosurveillance.org/ViewArticle.
aspx?ArticleId=19527.
38. Filia A, Bella A, Cadeddu G, et al. Extensive
Nosocomial Transmission of Measles Originating
in Cruise Ship Passenger, Sardinia,
Italy, 2014. Emerg Infect Dis 2015;211:444-6.
39. European Centre for Disease Prevention
and Control. Outbreak of measles linked to a
dog show in Slovenia, 8-9 November 2014 - 2
December 2014. Stockholm: ECDC, 2014.
40. European Centre for Disease Prevention
and Control. Outbreak of measles in France,
Haut-Rhin, April 2015. Stockholm: ECDC, 2015.
41. CDC Measles - United States, January 4-
April 2, 2015. MMWR 2015;64;373-6.
42. Comitato Nazionale per la Bioetica Mozione:
L’importanza delle vaccinazioni 24/04/
2015. http://presidenza.governo.it/bioetica/
mozioni/index.html.
43. Salmaso S. Cambiamenti delle politiche
vaccinali: la California sancisce la fine dell’esenzione
per opinioni personali. Epicentro, 3
settembre 2015. http://www.epicentro.iss.it/
temi/vaccinazioni/California2015.asp.
44. Pinto L, Bona G, Di Mauro G. Vaccinazioni
ed interesse superiore del fanciullo. Epicentro,
18 febbraio 2016. http://www.epicentro.
iss.it/temi/vaccinazioni/indice.asp. RIPPS 2016,
XI, 1, 64-7.
Corrispondenza: lucianopinto@virgilio.it